CTOs on the Move

Celator Pharmaceuticals

www.celatorpharma.com

 
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.celatorpharma.com
  • 200 PrincetonSouth Corporate Center Suite 180
    Ewing, NJ USA 08628
  • Phone: 609.243.0123

Executives

Name Title Contact Details

Funding

Celator Pharmaceuticals raised $32.5M on 08/22/2015

Similar Companies

Novocardia

Novocardia is on a mission to transform how cardiovascular disease care is delivered in the United States, and aims to help patients with heart and vascular disease live longer, healthier, and more satisfying lives. We are committed to putting cardiologists, and their patients, at the center of care by investing in our partner practices, deploying purpose-built data and analytics tools to improve patient outcomes, and enabling our partners to transition more successfully to value-based care.

MBF Healthcare Partners

MBF Healthcare Partners is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Motion Picture and Television Fund

MPTF supports our entertainment community in living and aging well, with dignity and purpose, and in helping each other in times of need.

MedServe

MedServe is a Bellaire, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.